B. Ruffell, D. Denardo, N. Affara, and L. Coussens, Lymphocytes in cancer development: Polarization towards pro-tumor immunity, Cytokine & Growth Factor Reviews, vol.21, issue.1, pp.3-10, 2010.
DOI : 10.1016/j.cytogfr.2009.11.002

R. Schreiber, L. Old, and M. Smyth, Cancer Immunoediting: Integrating Immunity's Roles in Cancer Suppression and Promotion, Science, vol.331, issue.6024, pp.1565-70, 2011.
DOI : 10.1126/science.1203486

G. Rabinovich and D. Croci, Regulatory Circuits Mediated by Lectin-Glycan Interactions in Autoimmunity and Cancer, Immunity, vol.36, issue.3, pp.322-357, 2012.
DOI : 10.1016/j.immuni.2012.03.004

F. Liu and G. Rabinovich, Galectins as modulators of tumour progression, Nature Reviews Cancer, vol.19, issue.1, pp.29-41, 2005.
DOI : 10.1038/nrc1275

M. Salatino and G. Rabinovich, Fine-Tuning Antitumor Responses Through the Control of Galectin???Glycan Interactions: An Overview, Meth Mol Biol, vol.677, pp.355-74, 2011.
DOI : 10.1007/978-1-60761-869-0_23

V. Thijssen, B. Barkan, H. Shoji, I. Aries, V. Mathieu et al., Tumor Cells Secrete Galectin-1 to Enhance Endothelial Cell Activity, Cancer Research, vol.70, issue.15, pp.6216-6240, 2010.
DOI : 10.1158/0008-5472.CAN-09-4150
URL : https://hal.archives-ouvertes.fr/hal-00505249

B. Rotblat, H. Niv, S. Andre, H. Kaltner, H. Gabius et al., Galectin-1(L11A) Predicted from a Computed Galectin-1 Farnesyl-Binding Pocket Selectively Inhibits Ras-GTP, Cancer Research, vol.64, issue.9, pp.3112-3120, 2004.
DOI : 10.1158/0008-5472.CAN-04-0026

M. Salatino, D. Croci, G. Bianco, J. Ilarregui, M. Toscano et al., Galectin-1 as a potential therapeutic target in autoimmune disorders and cancer, Expert Opinion on Biological Therapy, vol.60, issue.1, pp.45-57, 2008.
DOI : 10.1093/glycob/cwj056

N. Rubinstein, M. Alvarez, N. Zwirner, M. Toscano, J. Ilarregui et al., Targeted inhibition of galectin-1 gene expression in tumor cells results in heightened T cell-mediated rejection, Cancer Cell, vol.5, issue.3, pp.241-51, 2004.
DOI : 10.1016/S1535-6108(04)00024-8

A. Banh, J. Zhang, H. Cao, D. Bouley, S. Kwok et al., Tumor Galectin-1 Mediates Tumor Growth and Metastasis through Regulation of T-Cell Apoptosis, Cancer Research, vol.71, issue.13, pp.4423-4454, 2011.
DOI : 10.1158/0008-5472.CAN-10-4157

P. Kuo, M. Huang, D. Cheng, J. Hung, C. Yang et al., Lung Cancer-derived Galectin-1 Enhances Tumorigenic Potentiation of Tumor-associated Dendritic Cells by Expressing Heparin-binding EGF-like Growth Factor, Journal of Biological Chemistry, vol.287, issue.13, pp.9753-64, 2012.
DOI : 10.1074/jbc.M111.321190

P. Juszczynski, J. Ouyang, S. Monti, S. Rodig, K. Takeyama et al., The AP1-dependent secretion of galectin-1 by Reed Sternberg cells fosters immune privilege in classical Hodgkin lymphoma, Proceedings of the National Academy of Sciences, vol.104, issue.32, pp.13134-13143, 2007.
DOI : 10.1073/pnas.0706017104

M. Gandhi, G. Moll, C. Smith, U. Dua, E. Lambley et al., Galectin-1 mediated suppression of Epstein-Barr virus specific T-cell immunity in classic Hodgkin lymphoma, Blood, vol.110, issue.4, pp.1326-1335, 2007.
DOI : 10.1182/blood-2007-01-066100

R. Soldati, E. Berger, A. Zenclussen, G. Jorch, H. Lode et al., Neuroblastoma triggers an immunoevasive program involving galectin-1-dependent modulation of T cell and dendritic cell compartments, International Journal of Cancer, vol.30, issue.5, pp.1131-1172, 2012.
DOI : 10.1002/ijc.26498

Q. Le, G. Shi, H. Cao, D. Nelson, Y. Wang et al., Galectin-1: A Link Between Tumor Hypoxia and Tumor Immune Privilege, Journal of Clinical Oncology, vol.23, issue.35, pp.8932-8973, 2005.
DOI : 10.1200/JCO.2005.02.0206

D. Tang, Z. Yuan, X. Xue, Z. Lu, Y. Zhang et al., High expression of Galectin-1 in pancreatic stellate cells plays a role in the development and maintenance of an immunosuppressive microenvironment in pancreatic cancer, International Journal of Cancer, vol.68, issue.10, pp.2337-2385, 2012.
DOI : 10.1002/ijc.26290

F. Kovacs-solyom, A. Blasko, R. Fajka-boja, R. Katona, L. Vegh et al., Mechanism of tumor cell-induced T-cell apoptosis mediated by galectin-1, Immunology Letters, vol.127, issue.2, pp.108-126, 2010.
DOI : 10.1016/j.imlet.2009.10.003

F. Cedeno-laurent, R. Watanabe, J. Teague, T. Kupper, R. Clark et al., Galectin-1 inhibits the viability, proliferation, and Th1 cytokine production of nonmalignant T cells in patients with leukemic cutaneous T-cell lymphoma, Blood, vol.119, issue.15, pp.3534-3542, 2012.
DOI : 10.1182/blood-2011-12-396457

P. Kreunin, C. Yoo, V. Urquidi, D. Lubman, and S. Goodison, Proteomic profiling identifies breast tumor metastasis-associated factors in an isogenic model, PROTEOMICS, vol.65, issue.2, pp.299-312, 2007.
DOI : 10.1002/pmic.200600272

S. Xu, P. Yan, and Z. Shao, Differential proteomic analysis of a highly metastatic variant of human breast cancer cells using two-dimensional differential gel electrophoresis, Journal of Cancer Research and Clinical Oncology, vol.21, issue.10, pp.1545-56, 2010.
DOI : 10.1007/s00432-010-0812-0

E. Jung, H. Moon, B. Cho, C. Jeong, Y. Joo et al., Galectin-1 expression in cancer-associated stromal cells correlates tumor invasiveness and tumor progression in breast cancer, International Journal of Cancer, vol.7, issue.11, pp.2331-2339, 2007.
DOI : 10.1002/ijc.22434

M. Toscano, G. Bianco, J. Ilarregui, D. Croci, J. Correale et al., Differential glycosylation of TH1, TH2 and TH-17 effector cells selectively regulates susceptibility to cell death, Nature Immunology, vol.119, issue.8, pp.825-859, 2007.
DOI : 10.1038/ni1482
URL : https://hal.archives-ouvertes.fr/hal-00199622

M. Toscano, A. Commodaro, J. Ilarregui, G. Bianco, A. Liberman et al., Galectin-1 Suppresses Autoimmune Retinal Disease by Promoting Concomitant Th2- and T Regulatory-Mediated Anti-Inflammatory Responses, The Journal of Immunology, vol.176, issue.10, pp.6323-6355, 2006.
DOI : 10.4049/jimmunol.176.10.6323

J. He and L. Baum, Endothelial cell expression of galectin-1 induced by prostate cancer cells inhibits T-cell transendothelial migration, Laboratory Investigation, vol.271, pp.578-90, 2006.
DOI : 10.1083/jcb.200412032

L. Norling, A. Sampaio, D. Cooper, and M. Perretti, Inhibitory control of endothelial galectin-1 on in vitro and in vivo lymphocyte trafficking, The FASEB Journal, vol.22, issue.3, pp.682-90, 2008.
DOI : 10.1096/fj.07-9268com

J. Ilarregui, D. Croci, G. Bianco, M. Toscano, M. Salatino et al., Tolerogenic signals delivered by dendritic cells to T cells through a galectin-1-driven immunoregulatory circuit involving interleukin 27 and interleukin 10, Nature Immunology, vol.379, issue.9, pp.981-91, 2009.
DOI : 10.1038/ni.1772

F. Cedeno-laurent, M. Opperman, S. Barthel, V. Kuchroo, and C. Dimitroff, Galectin-1 Triggers an Immunoregulatory Signature in Th Cells Functionally Defined by IL-10 Expression, The Journal of Immunology, vol.188, issue.7, pp.3127-3164, 2012.
DOI : 10.4049/jimmunol.1103433

D. Baatar, P. Olkhanud, V. Wells, F. Indig, L. Mallucci et al., Tregs utilize ??-galactoside-binding protein to transiently inhibit PI3K/p21ras activity of human CD8+ T cells to block their TCR-mediated ERK activity and proliferation, Brain, Behavior, and Immunity, vol.23, issue.7, pp.1028-1065, 2009.
DOI : 10.1016/j.bbi.2009.06.003

M. Garin, C. Chu, D. Golshayan, E. Cernuda-morollon, R. Wait et al., Galectin-1: a key effector of regulation mediated by CD4+CD25+ T cells, Blood, vol.109, issue.5, pp.2058-65, 2007.
DOI : 10.1182/blood-2006-04-016451

B. Pulaski and S. Ostrand-rosenberg, Mouse 4T1 Breast Tumor Model, Curr Prot Immunol, vol.1, p.20, 2001.
DOI : 10.1002/0471142735.im2002s39

T. Yamaguchi, K. Hirota, K. Nagahama, K. Ohkawa, T. Takahashi et al., Control of Immune Responses by Antigen-Specific Regulatory T Cells Expressing the Folate Receptor, Immunity, vol.27, issue.1, pp.145-59, 2007.
DOI : 10.1016/j.immuni.2007.04.017

D. Croci, M. Salatino, N. Rubinstein, J. Cerliani, L. Cavallin et al., Disrupting galectin-1 interactions with Nglycans suppresses hypoxia-driven angiogenesis and tumorigenesis in Kaposi's sarcoma

P. Olkhanud, D. Baatar, M. Bodogai, F. Hakim, R. Gress et al., Breast Cancer Lung Metastasis Requires Expression of Chemokine Receptor CCR4 and Regulatory T Cells, Cancer Research, vol.69, issue.14, pp.5996-6004, 2009.
DOI : 10.1158/0008-5472.CAN-08-4619

A. Pedroza-gonzalez, K. Xu, T. Wu, C. Aspord, S. Tindle et al., Thymic stromal lymphopoietin fosters human breast tumor growth by promoting type 2 inflammation, The Journal of Experimental Medicine, vol.93, issue.3, pp.479-90, 2011.
DOI : 10.1038/ni.1852
URL : http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3058586

E. Danna, P. Sinha, M. Gilbert, V. Clements, B. Pulaski et al., Surgical Removal of Primary Tumor Reverses Tumor-Induced Immunosuppression Despite the Presence of Metastatic Disease, Cancer Research, vol.64, issue.6, pp.2205-2216, 2004.
DOI : 10.1158/0008-5472.CAN-03-2646

P. Olkhanud, B. Damdinsuren, M. Bodogai, R. Gress, R. Sen et al., Tumor-Evoked Regulatory B Cells Promote Breast Cancer Metastasis by Converting Resting CD4+ T Cells to T-Regulatory Cells, Cancer Research, vol.71, issue.10, pp.3505-3520, 2011.
DOI : 10.1158/0008-5472.CAN-10-4316

M. Chuck, M. Zhu, S. Shen, and W. Zhang, The Role of the LAT???PLC-??1 Interaction in T Regulatory Cell Function, The Journal of Immunology, vol.184, issue.5, pp.2476-86, 2010.
DOI : 10.4049/jimmunol.0902876

S. Shen, M. Chuck, M. Zhu, D. Fuller, C. Yang et al., The Importance of LAT in the Activation, Homeostasis, and Regulatory Function of T Cells, Journal of Biological Chemistry, vol.285, issue.46, pp.35393-405, 2010.
DOI : 10.1074/jbc.M110.145052

D. Croci and M. Salatino, Tumor Immune Escape Mechanisms that Operate During Metastasis, Current Pharmaceutical Biotechnology, vol.12, issue.11, pp.1923-1959, 2011.
DOI : 10.2174/138920111798376987

K. Ito and S. Ralph, Inhibiting galectin-1 reduces murine lung metastasis with increased CD4+ and CD8+ T cells and reduced cancer cell adherence, Clinical & Experimental Metastasis, vol.46, issue.10, pp.561-72, 2012.
DOI : 10.1007/s10585-012-9471-7

K. Ito, S. Scott, S. Cutler, L. Dong, J. Neuzil et al., Thiodigalactoside inhibits murine cancers by concurrently blocking effects of galectin-1 on immune dysregulation, angiogenesis and protection against oxidative stress, Angiogenesis, vol.194, issue.1, pp.293-307, 2011.
DOI : 10.1007/s10456-011-9213-5

C. Daroqui, J. Ilarregui, N. Rubinstein, M. Salatino, M. Toscano et al., Regulation of galectin-1 expression by transforming growth factor ??1 in metastatic mammary adenocarcinoma cells: implications for tumor-immune escape, Cancer Immunology, Immunotherapy, vol.209, issue.4, pp.491-500, 2007.
DOI : 10.1007/s00262-006-0208-9

P. Gromov, I. Gromova, J. Bunkenborg, T. Cabezon, J. Moreira et al., Up-regulated Proteins in the Fluid Bathing the Tumour Cell Microenvironment as Potential Serological Markers for Early Detection of Cancer of the Breast, Molecular Oncology, vol.4, issue.Suppl. 1, pp.65-89, 2010.
DOI : 10.1016/j.molonc.2009.11.003

W. Zhang, C. Sommers, D. Burshtyn, C. Stebbins, J. Dejarnette et al., Essential Role of LAT in T Cell Development, Immunity, vol.10, issue.3, pp.323-355, 1999.
DOI : 10.1016/S1074-7613(00)80032-1

C. Sommers, C. Park, J. Lee, C. Feng, C. Fuller et al., A LAT Mutation That Inhibits T Cell Development Yet Induces Lymphoproliferation, Science, vol.296, issue.5575, pp.2040-2043, 2002.
DOI : 10.1126/science.1069066

E. Aguado, S. Richelme, S. Nunez-cruz, A. Miazek, A. Mura et al., Induction of T Helper Type 2 Immunity by a Point Mutation in the LAT Adaptor, Science, vol.296, issue.5575, pp.2036-2076, 2002.
DOI : 10.1126/science.1069057

S. Koonpaew, S. Shen, L. Flowers, and W. Zhang, regulatory T cell development, The Journal of Experimental Medicine, vol.161, issue.1, pp.119-148, 2006.
DOI : 10.1084/jem.20041538

C. Chung, V. Patel, M. Moran, L. Lewis, and M. Miceli, Galectin-1 Induces Partial TCR ??-Chain Phosphorylation and Antagonizes Processive TCR Signal Transduction, The Journal of Immunology, vol.165, issue.7, pp.3722-3731, 2000.
DOI : 10.4049/jimmunol.165.7.3722

K. Stannard, P. Collins, K. Ito, E. Sullivan, S. Scott et al., Galectin inhibitory disaccharides promote tumour immunity in a breast cancer model, Cancer Letters, vol.299, issue.2, pp.95-110, 2010.
DOI : 10.1016/j.canlet.2010.08.005

T. Delaine, I. Cumpstey, L. Ingrassia, L. Mercier, M. Okechukwu et al., Galectin-Inhibitory Thiodigalactoside Ester Derivatives Have Antimigratory Effects in Cultured Lung and Prostate Cancer Cells, Journal of Medicinal Chemistry, vol.51, issue.24, pp.8109-8123, 2008.
DOI : 10.1021/jm801077j